CHG-2022-0227
Analytical Method Change for Thymosilib. New Dosage Strength for Thymosilib — major revision. Impacts 2 markets and 4 variations.
Change Number
CHG-2022-0227
Type
Analytical Method Change
Product
Status
Active
Owner
Tomoko Ikeda
Initiated
2022-01-12
Description
New Dosage Strength for Thymosilib — major revision
Impacted Markets (2)
BR — BrazilRU — Russia
Impacted Modules
3.2.S5.3.5
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|